JNJ (STOCKS)
Johnson & Johnson
$240.734800
+2.384800 (+1.00%)
Prev close: $238.350000
Company Information
- Exchange
- XNYS
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- CEO
- Joaquin Duato
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $580,183.53M
- Employees
- 139,800
- P/E (TTM)
- 21.60
- P/B (TTM)
- 7.23
- Dividend Yield
- 215.65%
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
6
Strong Buy
13
Buy
13
Hold
0
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Dec 2025 (Q4)
|
$2.46 | $2.46 | -0.0033 | -0.13% |
|
Sep 2025 (Q3)
|
$2.80 | $2.78 | +0.0152 | +0.55% |
|
Jun 2025 (Q2)
|
$2.77 | $2.71 | +0.0622 | +2.30% |
|
Mar 2025 (Q1)
|
$2.77 | $2.61 | +0.1558 | +5.96% |
Financial Statements
| Revenues | $92.15B |
| Benefits Costs and Expenses | $60.65B |
| Cost Of Revenue | $29.42B |
| Costs And Expenses | $60.65B |
| Gross Profit | $62.73B |
| Operating Expenses | $31.23B |
| Selling, General, and Administrative Expenses | $23.38B |
| Other Operating Expenses | $6.01B |
| Operating Income/Loss | $31.50B |
| Income/Loss From Continuing Operations After Tax | $25.12B |
| Income/Loss From Continuing Operations Before Tax | $31.50B |
| Income Tax Expense/Benefit | $6.38B |
| Income Tax Expense/Benefit, Deferred | $5.20B |
| Net Income/Loss | $25.12B |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | $25.12B |
| Net Income/Loss Available To Common Stockholders, Basic | $25.12B |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | $10.43 |
| Diluted Earnings Per Share | $10.35 |
| Basic Average Shares | 2,407,200,000 |
| Diluted Average Shares | 2,424,700,000 |
| Common Stock Dividends | $5.08 |
| Assets | $192.82B |
| Current Assets | $54.61B |
| Cash | $18.56B |
| Inventory | $14.15B |
| Other Current Assets | $21.90B |
| Noncurrent Assets | $138.21B |
| Fixed Assets | $22.34B |
| Intangible Assets | $48.74B |
| Other Non-current Assets | $67.13B |
| Liabilities | $113.54B |
| Current Liabilities | $50.87B |
| Accounts Payable | $9.63B |
| Wages | $3.97B |
| Other Current Liabilities | $37.27B |
| Noncurrent Liabilities | $62.67B |
| Equity | $79.28B |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $79.28B |
| Liabilities And Equity | $192.82B |
| Net Cash Flow From Operating Activities | $24.20B |
| Net Cash Flow From Operating Activities, Continuing | $24.20B |
| Net Cash Flow From Investing Activities | -$20.42B |
| Net Cash Flow From Investing Activities, Continuing | -$20.42B |
| Net Cash Flow From Financing Activities | -$5.51B |
| Net Cash Flow From Financing Activities, Continuing | -$5.51B |
| Exchange Gains/Losses | -$20.00M |
| Net Cash Flow | -$1.75B |
| Net Cash Flow, Continuing | -$1.73B |
| Comprehensive Income/Loss | $22.40B |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | $22.40B |
| Other Comprehensive Income/Loss | -$2.72B |